Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology.
about
Advances in neuroendocrine lung tumors.Large-cell neuroendocrine carcinoma of the lung.Neuroendocrine differentiation and neuroendocrine morphology as two different patterns in large-cell bronchial carcinomas: outcome after complete resectionClinical analysis of 50 Eastern Asian patients with primary pulmonary large-cell neuroendocrine carcinoma.Expression profiling and identification of potential molecular targets for therapy in pulmonary large-cell neuroendocrine carcinoma.Clinicopathological features and the impact of the new TNM classification of malignant tumors in patients with pulmonary large cell neuroendocrine carcinoma.Prognostic factors in neuroendocrine carcinoma: biological markers are more useful than histomorphological markers.Treatment options for patients with large cell neuroendocrine carcinoma of the lung.Klotho: a novel biomarker for cancer.Therapeutic biomarkers in lung neuroendocrine neoplasia.Human achaete-scute homolog-1 expression in neuroendocrine breast carcinoma.Multidisciplinary management of advanced lung neuroendocrine tumors.Treatment of lung large cell neuroendocrine carcinoma.Subgroup analysis of patients with G2 gastroenteropancreatic neuroendocrine tumors.WNT signaling - lung cancer is no exception.Mixed large cell neuroendocrine carcinoma and mucosa-associated lymphoid tissue lymphoma of the lung: A case report.Update on large cell neuroendocrine carcinoma.The role of surgery in high grade neuroendocrine tumours of the lung.Circulating chromogranin A and its fragments as diagnostic and prognostic disease markers.Pathological diagnosis of pulmonary large cell neuroendocrine carcinoma by endobronchial ultrasound-guided transbronchial needle aspiration.Large cell neuroendocrine carcinoma: retrospective analysis of 24 cases from four oncology centers in Turkey.Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Group†.p53 immunostaining is correlated with reduced survival and is not correlated with gene mutations in resected pulmonary large cell carcinomas.Array-based comparative genomic hybridization analysis of high-grade neuroendocrine tumors of the lung.Perioperative chemotherapy with pemetrexed and cisplatin for pulmonary large-cell neuroendocrine carcinoma: a case report and literature review.
P2860
Q34143347-ED886B52-AE0D-4739-AC56-DE3D1954DEC2Q34577968-6B4E7949-BF1B-4AF6-BF65-E0CA0FF9B4F9Q35040080-5BE90DEE-B4DA-4250-9090-026E396D658CQ35679386-5399A0EA-1F34-425F-8217-6992FB10E5BBQ36230888-00812768-7E57-4E0F-B6A1-832E6EBA139AQ37562236-D8E7F3CD-F4D4-4469-B512-7603B9594F1AQ37578830-3145CA2B-2806-4844-A536-C43715005D0EQ38203490-9F6F0356-F5D8-42BF-B6DE-C3789F63B1C1Q38236358-B4BD6013-7FF5-4423-97FD-8A9855E8B54EQ38253997-2D2E3859-15D5-41EF-86EC-1543AE9040B1Q38424985-49835C59-D17F-4CEF-A462-6940BA9A46ECQ38487554-022DF17D-8FE6-4428-9CB0-0FD4F4A657A5Q38760870-3E3B62B7-2CAA-4F53-946C-57869EEAB7C0Q40773502-1E50AFC1-66B0-4302-BDB6-4ED9C0D059B8Q41613396-123476CA-68D7-4D39-92E6-8FAB868FAD85Q42433680-969B978D-B04C-44E8-8F4E-047E3D8E8C84Q46316777-0EE0904B-B0C6-4301-82B2-82C9DCD1B6AAQ47117731-98561D01-3E2F-435C-9845-889160CC80E0Q47668183-059554BC-EFEB-43A1-9707-8C9B4E7BD886Q48357563-3231FA7B-1D8F-44BD-9AE6-C37469D164D2Q50050578-052EAFA7-09A2-4255-933A-1C64C27480D6Q52838432-874FCE8B-7BF9-43E2-8164-EDB4BD2DD8BAQ53537207-21E7B7E8-9688-452A-A36F-052D17DDB8F7Q53653077-81D87054-C251-4BF1-85C0-6ABFC52EB32FQ55107856-7480FD37-9FB0-490E-9FBD-50A9E46DD4A4
P2860
Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clinical characterization of p ...... ith neuroendocrine morphology.
@ast
Clinical characterization of p ...... ith neuroendocrine morphology.
@en
type
label
Clinical characterization of p ...... ith neuroendocrine morphology.
@ast
Clinical characterization of p ...... ith neuroendocrine morphology.
@en
prefLabel
Clinical characterization of p ...... ith neuroendocrine morphology.
@ast
Clinical characterization of p ...... ith neuroendocrine morphology.
@en
P2093
P2860
P1433
P1476
Clinical characterization of p ...... ith neuroendocrine morphology.
@en
P2093
P2860
P304
P356
10.1002/1097-0142(20010601)91:11<1992::AID-CNCR1224>3.0.CO;2-5
P407
P577
2001-06-01T00:00:00Z